MVision and OncoMed-Solutions partner in Eastern Europe & Russia
It is always a great pleasure to welcome new partners to our global network! This time, we are happy to announce a partnership with OncoMed-Solutions in Eastern Europe and Russia.…
Media
New partnership in Iberia
We are happy to announce a new partnership with DTA,S.L. in Iberia. Through the agreement, the Madrid-based company assumes responsibility for the distribution of MVision’s segmentation services in Spain and…
MVision in the UK & Ireland
The global MVision partner network continues to grow with new business partners in the UK and Ireland. We have entered into a long-term partnership with AMG MedTech Limited. Founded earlier…
MVision GDPR compliant SaaS segmentation service obtained CE certification for all major cancer sites
MVision AI OY, a Helsinki based startup company in the field of radiation oncology software services, announces the successful CE certification of all AI-based organ models. The latest version of…
Finnish AI software improves cancer patient care
Helsinki-based MVision developed AI software focusing on radiation treatment planning. Clinical use of the software was deployed in two Finnish hospitals last week. Radiotherapy plays an important role in cancer…
AI & Impact in Radiotherapy Treatment
What is MVision and how are we changing the face of cancer treatment? Check out the video with our founder and CEO Mahmudul Hasan and Dr. Heikki Minn from Turku University…
Research Paper: A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning
We are happy to announce the publication of our first peer-reviewed paper. The retrospective multicenter study proves that using a general deep learning-based automated segmentation tool for CT images indeed…
Logo
Download the official MVision logo here.